ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Moffitt Gets $100M From Fla. For Construction; Two Head And Neck Surgical Societies Merge

July 3, 1998

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Von Eschenbach’s Proposal for Plan B Fails to Impress Democrats, Angers Social Conservatives.

August 4, 2006

NCI Directory Delayed

January 27, 1984

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million

January 28, 1983